Skip to main content
Swing Capital

Nectar Lifescience Ltd

NSE: NECLIFE BSE: 532649

Nectar Lifescience Ltd (NECLIFE) is a Diversified company listed on NSE: NECLIFE | BSE: 532649. With a market cap of ₹233 Cr and ROCE of 5.36%, ROE of 11.2%, it operates in the Indian Diversified sector.

₹12
52W: ₹9.2 — ₹28.3
PE 0 · Book ₹32 · -63% vs book
Market Cap₹233 Cr
Stock P/E—Price to Earnings
ROCE5.36%Return on Capital
ROE11.2%Return on Equity
Div. Yield0%Face Value ₹1

Strengths

  • +Company has reduced debt.
  • +Stock is trading at 0.40 times its book value
  • +Promoter holding has increased by 6.93% over last quarter.
  • +Company's working capital requirements have reduced from 61.2 days to 43.0 days

Weaknesses

  • −Company has low interest coverage ratio.
  • −The company has delivered a poor sales growth of -6.74% over past five years.
  • −Company has a low return on equity of -5.45% over last 3 years.
  • −Contingent liabilities of Rs.134 Cr.

Shareholding Pattern

Promoters51.84%
FIIs0.6%
DIIs0.01%
Public43.52%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters55.8%55.8%44.53%▼11.344.53%44.53%44.91%▲0.444.91%51.84%▲6.9
FIIs16.6%3.24%▼13.40.73%▼2.51.65%▲0.90.82%▼0.80.62%▼0.20.52%▼0.10.6%▲0.1
DIIs0%0%0%0.15%▲0.10.19%▲0.00.08%▼0.10%▼0.10.01%▲0.0
Public27.57%40.94%▲13.454.72%▲13.853.64%▼1.154.45%▲0.854.37%▼0.148.73%▼5.643.52%▼5.2

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales3984524413596455431560
Expenses3714103933196410585662
Operating Profit27424940-145-154-10-2
OPM %7%9%11%11%-10%10%-36%-16%-6%0%
Net Profit121368-130-63-17614
EPS ₹0.050.070.030.130.250.35-5.8-2.82-7.850.64

AI Insights

Revenue Trend

TTM revenue at ₹442Cr, down 73.4% YoY. OPM at -36%.

Debt Position

Borrowings at ₹459Cr. Debt-to-equity ratio: 0.66x. Moderate leverage.

Institutional Flow

DIIs: 0.01% (+0.01pp change). FIIs: 0.6% (-15.40pp change). Promoters hold 51.84%.

Margin & Efficiency

ROCE declining from 12% (Mar 2014) to -5% (Mar 2025). Working capital days: 43.

Recent Announcements